Location > > PRODUCTS > PRODUCTS

Myocardial markers


Analysis Item English Abbreviation Clinical Application Sample Type Linearity Range
Cardiac Troponin I cTn I Myocardial infarction Whole blood, serum and plasma 0.2~50ng/mL
N-Terminal Pro-brain Natriuretic Peptide NT-proBNP Cardiac failure Whole blood, serum and plasma 200~30000pg/mL
Brain Natriuretic Peptide BNP Cardiac failure Whole blood, serum and plasma 20~5000pg/mL
Cardiac Troponin I/Myohemoglobin/Creatine Kinase Isoenzyme cTnI/Myo/CK-MB Myocardial infarction, myocardial damage, and differentiation of cardiogenic dyspnea and pulmonary dyspnea Whole blood, serum and plasma cTnI:0.2~50ng/mL;                       Myo:20~500ng/mL;                            CK-MB:2~100ng/mL
Heart-type Fatty Acid Binding Protein HFABP Early markers of acute myocardial infarction and myocardial damage Whole blood, serum and plasma 1~120ng/mL
D-Dimer D-D Deep venous thrombosis and pulmonary embolism exclusion diagnosis and thrombolysis effect assessment Whole blood and plasma 0.2~10.0µg/mL
Human Myeloperoxidase MPO Acute coronary syndrome and Myocardial infarction Whole blood, serum and plasma 12~1000ng/mL
Lipoprotein Phospholipase A2 Lp-PLA2 Atherosclerosis and cardio-cerebrovascular embolism Whole blood, serum and plasma 10~1000ng/mL
Soluble Growth Stimulating Expression Gene  2 Protein ST2 Heart failure markers Whole blood, serum and plasma 2~200ng/mL
 



上一篇:Cerebral Injury
下一篇:inflammation